Joel Greenblatt's CC Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 22,474 shares of The Chemours Company (CC) worth $264,968, representing 0.00% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 40 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in CC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2019, adding 868,284 shares. Largest reduction occurred in Q2 2019, reducing 1.33 M shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's The Chemours Company (CC) Holding Value Over Time
Track share changes against reported price movement
Quarterly The Chemours Company (CC) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -43,896 | Reduce 66.14% | 22,474 | $11.79 |
| Q3 2025 | +53,233 | Add 405.21% | 66,370 | $15.84 |
| Q2 2025 | -41,335 | Reduce 75.88% | 13,137 | $11.45 |
| Q1 2025 | +40,565 | Add 291.69% | 54,472 | $13.53 |
| Q4 2024 | +1,894 | Add 15.77% | 13,907 | $16.90 |
| Q3 2024 | -26,870 | Reduce 69.10% | 12,013 | $20.32 |
| Q2 2024 | +3,462 | Add 9.77% | 38,883 | $22.57 |
| Q1 2024 | -82,769 | Reduce 70.03% | 35,421 | $26.26 |
| Q4 2023 | +75,454 | Add 176.56% | 118,190 | $31.54 |
| Q3 2023 | -11,079 | Reduce 20.59% | 42,736 | $28.05 |
| Q2 2023 | +334 | Add 0.62% | 53,815 | $36.89 |
| Q1 2023 | +2,458 | Add 4.82% | 53,481 | $29.94 |
| Q4 2022 | +4,976 | Add 10.81% | 51,023 | $30.62 |
| Q3 2022 | -7,911 | Reduce 14.66% | 46,047 | $24.65 |
| Q2 2022 | -1,630 | Reduce 2.93% | 53,958 | $32.02 |
| Q1 2022 | -14,365 | Reduce 20.54% | 55,588 | $31.48 |
| Q4 2021 | -16,578 | Reduce 19.16% | 69,953 | $33.57 |
| Q3 2021 | +28,733 | Add 49.71% | 86,531 | $29.06 |
| Q2 2021 | -59,428 | Reduce 50.70% | 57,798 | $34.79 |
| Q1 2021 | -61,245 | Reduce 34.32% | 117,226 | $27.91 |
| Q4 2020 | -30,810 | Reduce 14.72% | 178,471 | $24.79 |
| Q3 2020 | -43,085 | Reduce 17.07% | 209,281 | $20.91 |
| Q2 2020 | -5,925 | Reduce 2.29% | 252,366 | $15.35 |
| Q1 2020 | +240,556 | Add 1356.39% | 258,291 | $8.87 |
| Q4 2019 | +17,735 | New Buy | 17,735 | $18.10 |
| Q2 2019 | -1.33 M | Sold Out | 0 | $0.00 |
| Q1 2019 | +868,284 | Add 189.35% | 1.33 M | $37.16 |
| Q4 2018 | +288,189 | Add 169.15% | 458,560 | $28.22 |
| Q3 2018 | +93,471 | Add 121.55% | 170,371 | $39.44 |
| Q2 2018 | -16,184 | Reduce 17.39% | 76,900 | $44.36 |
| Q1 2018 | -272,807 | Reduce 74.56% | 93,084 | $48.71 |
| Q4 2017 | +348,094 | Add 1955.91% | 365,891 | $50.06 |
| Q3 2017 | -12,015 | Reduce 40.30% | 17,797 | $50.63 |
| Q2 2017 | -182,987 | Reduce 85.99% | 29,812 | $37.90 |
| Q1 2017 | -741,132 | Reduce 77.69% | 212,799 | $38.50 |
| Q4 2016 | +337,415 | Add 54.73% | 953,931 | $22.09 |
| Q3 2016 | -663,133 | Reduce 51.82% | 616,516 | $16.00 |
| Q2 2016 | +788,668 | Add 160.63% | 1.28 M | $8.24 |
| Q1 2016 | +480,925 | Add 4782.47% | 490,981 | $7.00 |
| Q4 2015 | +10,056 | New Buy | 10,056 | $5.37 |
Joel Greenblatt's The Chemours Company Investment FAQs
Joel Greenblatt first purchased The Chemours Company (CC) in Q4 2015, acquiring 10,056 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held The Chemours Company (CC) for 40 quarters since Q4 2015.
Joel Greenblatt's largest addition to The Chemours Company (CC) was in Q1 2019, adding 1,326,844 shares worth $49.31 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 22,474 shares of The Chemours Company (CC), valued at approximately $264,968.
As of the Q4 2025 filing, The Chemours Company (CC) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in The Chemours Company (CC) was 1,326,844 shares, as reported at the end of Q1 2019.